• Biogen named Michael J. Parini as chief legal officer, effective Aug. 3, 2026.
• Parini will join the executive committee, reporting to CEO Christopher A. Viehbacher.
• He most recently served as CEO of Spur Therapeutics, leading a strategic reset and advancing a rare-disease program into Phase 3.
• Earlier roles include chief administrative, legal and business development officer at Vertex Pharmaceuticals, following senior legal posts at Pfizer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biogen Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607150815PRIMZONEFULLFEED9762640) on July 15, 2026, and is solely responsible for the information contained therein.